anti-human VEGF165b monoclonal antibody Anti-Human 50 µg,Reliatech,101-M180
This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse immunized with recombinant human VEGF-165b C-terminal peptide. IgG1 fraction of the tissue culture supernatant was purified by Protein G affinity chromatograph
Host
Mouse
Reactivity
Human
Application
WB, IHC
Platform ID
BAB876682423
Reliatech
Contact
Tel: +49 (0) 5331 - 8586987
Fax: +49 (0) 5331- 8586989
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
Nameanti-human VEGF165b monoclonal antibody Anti-Human 50 µg
Cat. No.101-M180
Accession NumberP15692-8
HostMouse
IsotypeIgG1
ReactivityHuman
ApplicationWB, IHC
Clone Number(#7F17)
Appearance/Formlyophilized
FormulationPBS
ReconstitutionCentrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.
StorageLyophilized samples are stable for 2 years from date of receipt when stored at -20°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity.
Regulatory StatusFor research use only
Scientific Background
VEGF165b is an mRNA splice variant of VEGF. Alternative exon usage results in a 165 aa product that is identical to VEGF165 except for 6 unique amino acids at the C-terminus. VEGF165b inhibits proliferation and migration of endothelial cells and is down-regulated in renal cell carcinomas.
Synonyms
vascular endothelial growth factor A; VEGFA; VPF; VEGF; MVCD1
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.